Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RHHBY ROCHE HOLDING AG > Key Indicators
RHHBY ROCHE HOLDING AG
40.820
-0.260-0.63%
Post Mkt Price
40.8200.0000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(FY)2021/12/31(Q4)2021/12/31(Q2)2021/06/30
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
-9.62% 138.5996 -5.06% 135.714 -5.06% 135.714 5.98% 153.3557
Receivable Turnover(T)
11.86% 5.7319 4.68% 5.7261 4.68% 5.7261 -0.43% 5.1243
Inventory Turnover(T)
7.98% 2.4853 7.93% 2.6356 7.93% 2.6356 -12.07% 2.3016
Fixed Assets Turnover(T)
5.36% 2.6482 5.21% 2.6342 5.21% 2.6342 -3.24% 2.5135
Total Asset Rate(T)
3.81% 0.7374 2.11% 0.7038 2.11% 0.7038 -5.40% 0.7103
ROIC
-1.61% 28.546% -10.85% 26.269% -10.85% 26.269% 1.62% 29.012%
ROE
15.04% 46.528% 10.68% 45.800% 10.68% 45.800% -7.03% 40.446%
ROA
0.74% 16.787% -7.59% 15.612% -7.59% 15.612% 3.25% 16.665%
FCF to Sales
17.36% 27.635% 28.46% 26.157% 28.46% 26.157% -9.71% 23.546%
FCF to Net Income
20.95% 121.389% 41.95% 117.925% 41.95% 117.925% -17.28% 100.364%
Efficiency Ratios
ROE 5 Year Average
-- -- 1.55% 41.006% -- -- -- --
ROA 5 Year Average
-- -- 4.31% 14.798% -- -- -- --
Average 5 Years ROIC
-- -- 2.83% 25.908% -- -- -- --
Profitability Ratios TTM
Gross Margin
-4.19% 67.939% -4.91% 68.715% -4.91% 68.715% -0.12% 70.908%
Operating Margin
1.29% 30.482% -9.07% 28.909% -9.07% 28.909% 4.58% 30.093%
Net Margin
-2.96% 22.765% -9.50% 22.181% -9.50% 22.181% 9.14% 23.461%
EBITDA Margin
-5.97% 0.3585% -10.41% 0.3545% -10.41% 0.3545% 6.79% 0.3812%
R & D Expense Ratio
-1.69% 22.660% 5.60% 23.560% 5.60% 23.560% 6.91% 23.050%
Sales Expense Ratio
-3.02% 15.400% -3.72% 15.800% -3.72% 15.800% -9.93% 15.880%
Administration Expense Rate
-14.80% 4.950% 1.53% 5.300% 1.53% 5.300% -10.75% 5.810%
Financial Health Ratios
Long-Term Debt to Equity Ratio
197.57% 88.805% 128.71% 69.831% 128.71% 69.831% -24.72% 29.843%
Total Assets to Common Equity
48.16% 344.341% 59.04% 376.973% 59.04% 376.973% -8.87% 232.419%
Debt to Asset Ratio
177.52% 110.167% 213.45% 132.925% 213.45% 132.925% -16.85% 39.697%
Current Ratio
-10.85% 1.1062 -28.49% 0.9274 -28.49% 0.9274 0.61% 1.2408
Quick Ratio
-17.69% 0.6427 -27.71% 0.6924 -27.71% 0.6924 -2.10% 0.7809
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- 10.77% 3.377% -- -- -- --
Revenue CAGR(5Y)
-- -- 13.17% 4.425% -- -- -- --
Net Income CAGR(3Y)
-- -- -46.03% 9.881% -- -- -- --
Net Income CAGR(5Y)
-- -- -22.41% 7.784% -- -- -- --
Dividend CAGR(3Y)
-- -- 82.45% 3.671% -- -- -- --
Dividend CAGR(5Y)
-- -- -4.75% 2.528% -- -- -- --
FCF 1 Year Growth
-- -- 219.40% 38.321% -- -- -- --
FCF CAGR(3Y)
-- -- 160.02% 2.945% -- -- -- --
FCF CAGR(5Y)
-- -- 736.54% 10.757% -- -- -- --
Currency Unit
CHFCHFCHFCHF

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Roche Holding AG operates as a research healthcare company. It operates through the following divisions: Pharmaceuticals and Diagnostics. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
CEO: Dr. Severin Schwan
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist